Functionalized TMD Nanosheets for Sepsis Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current therapeutic agents for sepsis and septic shock are ineffective in managing excessive inflammatory responses and oxidative stress, leading to organ damage and high mortality rates.

Innovation Solution

A pharmaceutical composition comprising a 2D transition metal dichalcogenide (TMD) functionalized with an amphiphilic block polymer compound, specifically polyethylene oxide (PEO) and poly(ε-caprolactone) (PCL), which scavenges reactive oxygen and nitrogen species and inhibits inflammatory cytokine secretion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional therapeutic agents are used to treat sepsis, then the treatment approach is simple and well-established, but the agents fail to effectively manage excessive inflammatory responses and oxidative stress

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidcomplexity of therapeutic agent
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs a composite material consisting of transition metal dichalcogenide (TMD) nanosheets functionalized with amphiphilic block copolymers. The TMD core provides antioxidant activity to scavenge ROS and RNS, while the amphiphilic polymer coating enables water solubility and biocompatibility. This composite structure combines the therapeutic benefits of inorganic nanomaterials with the advantages of biopolymer functionalization, achieving effective sepsis treatment through dual mechanisms of antioxidant and anti-inflammatory activity.

Inventive Principle:
Principle #40Composite materials

2Reliability

If 2D TMD nanosheets are used to scavenge ROS and RNS, then antioxidant activity is improved, but water solubility and biocompatibility are insufficient

Engineering Contradiction:
Improveantioxidant activityVSAvoidwater solubility
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent modifies the surface properties of TMD nanosheets by functionalizing them with amphiphilic block copolymers. This chemical modification changes the surface parameters of the nanosheets, introducing hydrophilic groups that enhance water solubility while maintaining the hydrophobic core that provides antioxidant activity. The functionalization process transforms the original insoluble TMD into a water-dispersible nanomedicine suitable for biological applications.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The amphiphilic block copolymer acts as an intermediary between the hydrophobic TMD nanosheet core and the aqueous biological environment. The copolymer's hydrophobic segment interacts with the TMD surface, while its hydrophilic segment extends into the water phase, facilitating dispersion and enhancing biocompatibility. This intermediary layer enables the TMD nanosheets to function effectively in physiological conditions without compromising their antioxidant properties.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If amphiphilic block polymer functionalization is applied to TMD, then water solubility and biocompatibility are improved, but the structural complexity of the therapeutic agent increases

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidstructural complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The amphiphilic block copolymer is segmented into distinct hydrophobic and hydrophilic blocks, each performing specific functions. The hydrophobic block (e.g., poly(ε-caprolactone)) anchors to the TMD surface, while the hydrophilic block (e.g., polyethylene oxide) provides water solubility. This segmentation allows the complex molecule to be designed with modular functionality, where each segment contributes to a specific property, simplifying the overall design logic despite the molecular complexity.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The functionalized TMD nanosheets effectively reduce oxidative stress and inflammatory cytokine secretion, improving survivability and reducing bacterial loads in sepsis models, thereby providing a promising anti-inflammatory and antioxidant treatment for sepsis and septic shock.

Implementation Method 1

the applicability of 2D TMDs functionalized with amphiphilic block polymer compounds for antioxidant use has been proposed

Methodology Applied
Scientific EffectRadical scavenging: Oxidation

Implementation Method 2

a 2D transition metal dichalcogenide (TMD) functionalized with an amphiphilic block polymer compound including a hydrophilic block and a hydrophobic block

Methodology Applied
Scientific EffectAmphiphilic interaction: Amphiphiles

Data Source

PatentUS20230256003A1Pharmaceutical composition for preventing or treating sepsis containing functionalized transition metal dichalcogenide
Publication Date: 2023.08.17 IND UNIV COOP FOUND HANYANG UNIV ERICA CAMPUS
  • US20230256003A1 patent drawing
  • US20230256003A1 patent drawing
  • US20230256003A1 patent drawing

AI summary

A 2D TMD nanosheet functionalized with an amphiphilic block polymer compound of the present disclosure has scavenging activity for intracellular and mitochondrial ROS and the scavenging activity is maintained well at low pH, and further, inhibits the excessively increased secretion of inflammatory cytokines in microbial infection, exhibits antibacterial activity, and can increase survivability and prevent aggravation of symptoms in an animal model of sepsis, it can be provided as an anti-inflammatory/antioxidant agent for prevention and treatment of sepsis and septic shock.